Mineralys Therapeutics MLYS
$13.66 −$0.50 (-3.53%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $13.70 +0.29%
Open$13.81
Prev close$14.16
Day range$13.57 – $14.79
Volume1.35M
Market cap$1.21B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts6
Average target$45.50+233.1% vs. price
- Buy 83%
- Hold 17%
Low $19.00Now $13.66Avg $45.50High $56.00
Recent rating changes
The last 20 actions on file set price targets from $19.00 to $56.00, averaging $47.83.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 10 Nov 2026 | H.C. Wainwright | BUY | $56.00 |
| 9 Nov 2026 | H.C. Wainwright | BUY | $56.00 |
| 6 Nov 2026 | UBS | HOLD | $19.00 |
| 5 Nov 2026 | TD Cowen | BUY | – |
| 5 Nov 2026 | Wells Fargo | BUY | $55.00 |
| 5 Nov 2026 | BofA Securities | BUY | – |
| 5 Nov 2026 | Stifel | BUY | $52.00 |
| 5 Nov 2026 | H.C. Wainwright | BUY | $56.00 |
| 23 Oct 2026 | H.C. Wainwright | BUY | $56.00 |
| 12 Oct 2026 | UBS | HOLD | $29.00 |
| 12 Oct 2026 | BofA Securities | BUY | $49.00 |
| 12 Oct 2026 | H.C. Wainwright | BUY | $56.00 |
| 11 Oct 2026 | UBS | HOLD | $29.00 |
| 12 Aug 2026 | Wells Fargo | BUY | $55.00 |
| 12 Aug 2026 | LifeSci Capital | BUY | $54.00 |
| 12 Aug 2026 | BofA Securities | BUY | $49.00 |
| 12 Aug 2026 | Goldman Sachs | BUY | $40.00 |
| 12 Aug 2026 | Guggenheim | BUY | $52.00 |
| 12 Aug 2026 | H.C. Wainwright | BUY | $56.00 |
| 3 Jun 2026 | Goldman Sachs | BUY | $42.00 |
No comments yet — be the first to weigh in on MLYS.
Sign in to join the discussion.